Zobrazeno 1 - 10
of 178
pro vyhledávání: '"Taimour Y. Langaee"'
Autor:
Nida Waheed, Michael G. Fradley, David L. DeRemer, Ahmad Mahmoud, Chintan P. Shah, Taimour Y. Langaee, Gloria P. Lipori, Keith March, Carl J. Pepine, Rhonda M. Cooper-DeHoff, Yonghui Wu, Yan Gong
Publikováno v:
Cardio-Oncology, Vol 7, Iss 1, Pp 1-7 (2021)
Abstract Background Immune checkpoint inhibitors (ICIs) are a novel class of anticancer agents that have demonstrated clinical response for both solid and hematological malignancies. ICIs are associated with development of immune-related adverse even
Externí odkaz:
https://doaj.org/article/eb7e60208f7745ba8dc1a5a95738d23d
Autor:
Ana Caroline C. Sá, Amy Webb, Yan Gong, Caitrin W. McDonough, Mohamed H. Shahin, Somnath Datta, Taimour Y. Langaee, Stephen T. Turner, Amber L. Beitelshees, Arlene B. Chapman, Eric Boerwinkle, John G. Gums, Steven E. Scherer, Rhonda M. Cooper-DeHoff, Wolfgang Sadee, Julie A. Johnson
Publikováno v:
BMC Medical Genomics, Vol 11, Iss 1, Pp 1-9 (2018)
Abstract Background Recently, 34 genes had been associated with differential expression relative to blood pressure (BP)/ hypertension (HTN). We hypothesize that some of the genes associated with BP/HTN are also associated with BP response to antihype
Externí odkaz:
https://doaj.org/article/0e2dbd26f75946c0b4dacc18b645c125
Autor:
Jatinder K. Lamba, Bernadett Balla, L. Shannon Holliday, Taimour Y. Langaee, Caitrin W. McDonough, Douglas K. Price, Danxin Wang, P. Lakatos, Joseph Katz, Sara L. Van Driest, William D. Figg, Sonal Singh, Jan S. Moreb, János P. Kósa, Guang Yang, Gian Andrea Pelliccioni, Yan Gong, Issam Hamadeh
Publikováno v:
Clinical pharmacology and therapeutics
Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious drug-related adverse event. To identify pharmacogenomic markers of MRONJ associated with bisphosphonate therapy, we conducted a genomewide association study (GWAS) meta-analysi
Autor:
Serene Joseph, Charles E. Wood, Taimour Y. Langaee, Maureen Keller-Wood, Abhisheak Sharma, Peter W. Stacpoole, Lloyd P. Horne, Margaret O. James
Publikováno v:
Drug Metabolism and Disposition. 49:451-458
Sodium dichloroacetate (DCA) is an investigational drug that shows promise in the treatment of acquired and congenital mitochondrial diseases, including myocardial ischemia and failure. DCA increases glucose utilization and decreases lactate producti
Autor:
Kristin Wiisanen, Yan Gong, Caitrin W. McDonough, Julie A. Johnson, Amanda R. Elsey, Larisa H. Cavallari, Taimour Y. Langaee, Meghan J. Arwood, Reginald F. Frye
Publikováno v:
JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 4:343-351
Autor:
Zhichuan Li, Danxin Wang, Liang Zhao, Scott A. Mosley, Yan Gong, Rhonda M. Cooper-DeHoff, Minori Kinjo, Reginald F. Frye, Cameron D. Thomas, Taimour Y. Langaee, Arlene B. Chapman, Sarah Kim, Hyewon Kim, Larisa H. Cavallari, Issam Hamadeh, John G. Gums, David S. Estores, Siegfried Schmidt, Lanyan Fang, Julie A. Johnson, Stephan Schmidt, Nihal El Rouby, Karthik Lingineni, Kairui Feng, Philip F. Binkley
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
Recent CYP2D6 phenotype standardization efforts by CYP2D6 activity score (AS) are based on limited pharmacokinetic (PK) and pharmacodynamic (PD) data. Using data from two independent clinical trials of metoprolol, we compared metoprolol PK and PD acr
Autor:
Joseph M Collins, L. Shannon Holliday, P. Lakatos, Taimour Y. Langaee, Gian Andrea Pelliccioni, Jatinder K. Lamba, Joseph Katz, Mihály Vaszilkó, Roya Rafiee, János P. Kósa, Bernadett Balla, Yan Gong, Sonal Singh, Jan S. Moreb, Guang Yang, Young Sick Kim, Caitrin W. McDonough, Danxin Wang
Publikováno v:
J Bone Miner Res
Medication-related osteonecrosis of the jaw (MRONJ) is a rare but serious adverse drug reaction. Our previous whole-exome sequencing study found SIRT1 intronic region single-nucleotide polymorphism (SNP) rs7896005 to be associated with MRONJ in cance
Autor:
Richard J. Marrero, Taimour Y. Langaee, Elizabeth M. Eddy, Meghan J. Arwood, Kimberly J. Newsom, Brian Hemendra Ramnaraign, Michael J. Clare-Salzer, Karen Daily, Rhonda M. Cooper-DeHoff, David L. DeRemer, Petr Starostik, Dennie Jones, Emily J. Cicali, Julie A. Johnson, Thomas J. George, Kelsey J. Cook, Larisa H. Cavallari, Kristin Weitzel
Publikováno v:
Clin Pharmacol Ther
There have been significant advancements in precision medicine and approaches to medication selection based on pharmacogenetic results. With the availability of direct-to-consumer genetic testing and growing awareness of genetic interindividual varia
Autor:
Richard H. Wagner, Gurjit S. Sidhu, Layla Schuster, Eric Li, Lin Liu, Taimour Y. Langaee, Gary P. Wang, Ryan Tamashiro
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
HIV drug resistance is a major threat to achieving long-term viral suppression in HIV-positive individuals. Drug resistant HIV variants, including minority variants, can compromise response to antiretroviral therapy. Many studies have investigated th
Autor:
Alberto Riva, Francesco Franchi, Nihal El Rouby, Larisa H. Cavallari, Gloria Lipori, Amanda R. Elsey, Adel Alrwisan, Julie A. Johnson, Dominick J. Angiolillo, Taimour Y. Langaee, Almut G. Winterstein
Publikováno v:
Clinical and Translational Science
Clinical and Translational Science, Vol 13, Iss 3, Pp 473-481 (2020)
Clinical and Translational Science, Vol 13, Iss 3, Pp 473-481 (2020)
We aimed to estimate the utility of panel‐based pharmacogenetic testing of patients undergoing percutaneous coronary intervention (PCI). Utilization of Clinical Pharmacogenetic Implementation Consortium (CPIC) level A/B drugs after PCI was estimate